sodium bisulfide has been researched along with Cardiac Toxicity in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aponte, AM; Gucek, M; Menazza, S; Murphy, E; Steenbergen, C; Sun, J | 1 |
| Guo, DM; He, H; He, J; Jiang, ZS; Liu, MH; Peng, J; Tan, TP; Tang, ZH; Wu, SJ; Zhang, Y | 1 |
2 other study(ies) available for sodium bisulfide and Cardiac Toxicity
| Article | Year |
|---|---|
Additive cardioprotection by pharmacological postconditioning with hydrogen sulfide and nitric oxide donors in mouse heart: S-sulfhydration vs. S-nitrosylation.
Topics: Animals; Cardiotoxicity; Hydrogen Sulfide; Ischemic Postconditioning; Mice, Inbred C57BL; NADPH Oxidases; Nitric Oxide; Nitric Oxide Donors; Sulfides | 2016 |
Hydrogen sulfide protects H9c2 cardiac cells against doxorubicin-induced cytotoxicity through the PI3K/Akt/FoxO3a pathway.
Topics: Acetylcysteine; Animals; Apoptosis; Cardiotonic Agents; Cardiotoxicity; Cell Line; Chromones; Doxorubicin; Forkhead Box Protein O3; Gene Expression Regulation; Hydrogen Sulfide; Models, Biological; Morpholines; Myocytes, Cardiac; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Phosphorylation; Proto-Oncogene Proteins c-akt; Rats; Signal Transduction; Sulfides | 2016 |